全文获取类型
收费全文 | 18455篇 |
免费 | 820篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 248篇 |
儿科学 | 412篇 |
妇产科学 | 418篇 |
基础医学 | 2807篇 |
口腔科学 | 422篇 |
临床医学 | 1429篇 |
内科学 | 3620篇 |
皮肤病学 | 473篇 |
神经病学 | 1792篇 |
特种医学 | 1084篇 |
外国民族医学 | 2篇 |
外科学 | 2563篇 |
综合类 | 117篇 |
一般理论 | 3篇 |
预防医学 | 892篇 |
眼科学 | 416篇 |
药学 | 1567篇 |
中国医学 | 71篇 |
肿瘤学 | 979篇 |
出版年
2021年 | 193篇 |
2020年 | 160篇 |
2019年 | 178篇 |
2018年 | 316篇 |
2017年 | 244篇 |
2016年 | 315篇 |
2015年 | 424篇 |
2014年 | 500篇 |
2013年 | 614篇 |
2012年 | 917篇 |
2011年 | 1037篇 |
2010年 | 597篇 |
2009年 | 534篇 |
2008年 | 938篇 |
2007年 | 987篇 |
2006年 | 993篇 |
2005年 | 966篇 |
2004年 | 961篇 |
2003年 | 903篇 |
2002年 | 954篇 |
2001年 | 405篇 |
2000年 | 419篇 |
1999年 | 429篇 |
1998年 | 216篇 |
1997年 | 193篇 |
1996年 | 154篇 |
1995年 | 127篇 |
1994年 | 128篇 |
1993年 | 129篇 |
1992年 | 200篇 |
1991年 | 178篇 |
1990年 | 164篇 |
1989年 | 190篇 |
1988年 | 152篇 |
1987年 | 149篇 |
1986年 | 143篇 |
1985年 | 152篇 |
1984年 | 113篇 |
1983年 | 108篇 |
1982年 | 104篇 |
1981年 | 102篇 |
1979年 | 129篇 |
1978年 | 97篇 |
1977年 | 117篇 |
1976年 | 98篇 |
1975年 | 109篇 |
1974年 | 108篇 |
1973年 | 103篇 |
1972年 | 97篇 |
1969年 | 90篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Thorsten Gerstner Deike Buesing Elke Longin Claudia Bendl Dieter Wenzel Brigitte Scheid Gisela Goetze Alfons Macke Gerhard Lippert Wolfgang Klostermann Geert Mayer Regine Augspach-Hofmann Sabine Fitzek Carl-Albrecht Haensch Markus Reuland Stephan A Koenig 《Seizure》2006,15(6):443-448
Valproic acid (VPA) is a broad-spectrum antiepileptic drug and is usually well-tolerated. Rare serious complications may occur in some patients, including haemorrhagic pancreatitis, bone marrow suppression, VPA-induced hepatotoxicity and VPA-induced encephalopathy. The typical signs of VPA-induced encephalopathy are impaired consciousness, sometimes marked EEG background slowing, increased seizure frequency, with or without hyperammonemia. There is still no proof of causative effect of VPA in patients with encephalopathy, but only of an association with an assumed causal relation. We report 19 patients with VPA-associated encephalopathy in Germany from the years 1994 to 2003, none of whom had been published previously. 相似文献
43.
Björn-Christian Link Emre F. Yekebas Dean Bogoevski Asad Kutup Gerhard Adam Jakob R. Izbicki Gerrit Krupski 《Journal of gastrointestinal surgery》2007,11(2):166-170
Symptomatic biliary leakage following major upper abdominal surgery is a severe complication resulting in increased morbidity
and mortality. Treatment options usually include either endoscopic intervention or surgical revision. These options may be
burdened by a high perioperative risk for the patient (e.g., patients with severe disease) or simply may not be possible (e.g.,
nonpreserved gastroduodenal passage). In the past, percutaneous transhepatic cholangiodrainage did only seem to be a viable
option for patients with dilated bile ducts. Here, we present our experience in a consecutive series of patients with symptomatic
biliary leakage following major upper abdominal surgery and without dilation of the biliary system that underwent percutaneous
transhepatic cholangiodrainage. Percutaneous transhepatic cholangiodrainage was feasible in 15 of 18 patients (83.3%). The
procedure was technically not possible in three patients (16.7%). In 10 of the 15 patients (66.6%) with feasible percutaneous
transhepatic cholangiodrainage, biliary leakage was definitely controlled without the need for surgical revision. Depending
on the experience with the interventional procedure, percutaneous transhepatic cholangiodrainage should be considered as an
alternative for treatment of symptomatic biliary leakage instead of immediate reoperation.
Presented at the Digestive Disease Week 2005 (DDW), Chicago, IL, May 14–19, 2005 (poster presentation). 相似文献
44.
Prof. Dr. Bernhard Schmitt Prof. Dr. Michael Albani Priv.-Doz. Dr. Thomas Bast Prof. Dr. Ulrich Brandl Prof. Dr. Rudolf Korinthenberg Prof. Dr. Gerhard Kurlemann Prof. Dr. Bernd Neubauer Prof. Dr. Ulrich Stephani Dr. Markus Wolff 《Zeitschrift für Epileptologie》2007,20(3):113-119
Zusammenfassung
Der richtige Zeitpunkt für das Absetzen der Antiepileptika (AE) im Kindesalter ist unbekannt. Anl?sslich ihrer Jahrestagung
haben die Mitglieder des K?nigsteiner Arbeitskreises (KA) eigene und publizierte Absetzstrategien diskutiert. Da Studien zu
diesem Thema rar und widersprüchlich sind, wurde beschlossen, die Diskussionsergebnisse im Sinne einer Meinungs?u?erung zu
publizieren.
Bei Neugeborenen besteht übereinstimmung, AE innerhalb von 2 bis 12 Wochen nach dem letzten Anfall abzusetzen. Bei BNS-Epilepsie
wird Vigabatrin nach 6 bis 12 und Sultiam nach 6 bis 36 Monaten abgesetzt. Nach erfolgreicher Steroidtherapie setzt die Mehrheit
des KA die AE-Therapie für zwei Jahre fort. Für die Rolando-Epilepsie sind 1 bis 3 Jahre Anfallsfreiheit ausreichend, auch
wenn fokale Spike-Waves persistieren. Im Falle einer symptomatisch fokalen Epilepsie ist die Grunderkrankung mitentscheidend
für das Absetzen. Die Behandlung der Absencen-Epilepsie kann nach zwei Jahren beendet werden, w?hrend bei myoklonisch- astatischer
Epilepsie meist eine 2- bis 5-j?hrige Anfallsfreiheit vorausgesetzt wird. Konsens besteht darüber, dass die Juvenile- Myoklonus-Epilepsie
ein sehr hohes Rückfallrisiko birgt. Dennoch ziehen einzelne neurop?diatrische Mitglieder einen Absetzversuch nach 2- bis
3-j?hriger Anfallsfreiheit in Betracht. Die überwiegende Mehrheit des KA führt aber bei gesicherter Diagnose keinen Absetzversuch
durch. Bezüglich der Absetzgeschwindigkeit wird ein langsames (3 bis 12 Monate) Ausschleichen favorisiert. Nur zwei Mitglieder
praktizieren ein rascheres Absetzen (<3 Monaten). Das EEG spielt für die Entscheidung eine untergeordnete Rolle und bleibt
auf bestimmte Epilepsieformen (z. B. Absencen-Epilepsie) beschr?nkt.
Das vorliegende Papier gibt die Meinung des KA wieder und eignet sich nicht im Sinne einer Leitlinie. Für die Entscheidung
AE abzusetzen, ist immer eine individuelle Abw?gung von Grunderkrankung, Epilepsieform und psychosozialen Umst?nde erforderlich.
相似文献
45.
46.
Urban Sester Barbara C. Gärtner Heinrike Wilkens Bernhard Schwaab Rolf Wössner Ingrid Kindermann Matthias Girndt reas Meyerhans Nikolaus Mueller-Lantzsch Hans-Joachim Schäfers Gerhard W. Sybrecht Hans Köhler Martina Sester 《American journal of transplantation》2005,5(6):1483-1489
Patients after kidney, heart and lung transplantation differ in their immunosuppressive drug regimens and in susceptibility to infectious complications with cytomegalovirus (CMV). In this study, CMV-specific T-cell responses were characterized in long-term transplant recipients and associated with the frequency of infectious complications. CMV-reactive CD4 T cells from 50 healthy controls, 68 renal, 14 heart and 24 lung transplant recipients were flow cytometrically quantified by the induction of cytokines after specific stimulation. Moreover, the immunosuppressive effect of calcineurin inhibitors on specific T-cell reactivity was quantified in vitro and compared with responses in vivo. Median CMV-specific T-cell frequencies in long-term renal (1.48%; range 0.06-17.26%) and heart transplant recipients (0.90%; 0.13-12.49%) did not differ from controls (1.82%; 0.26-21.00%). In contrast, CMV-specific T-cell levels were significantly lower in lung transplant recipients (0.50%; <0.05-4.98%) and showed a significant correlation with the frequency of infectious episodes (r =-0.57, p = 0.005). The differences within the groups were associated with increasing dosages of immunosuppressive drugs, as exemplified for calcineurin inhibitors that dose dependently reduced specific T-cell reactivity in vitro. In conclusion, monitoring CMV-specific CD4 T cells may serve as a measure for long-term disease susceptibility and may contribute to an improved management of CMV complications after lung transplantation. 相似文献
47.
Gerhard H. Schlund 《MedR Medizinrecht》2007,25(9):572
Ohne Zusammenfassung 相似文献
48.
Heinrich Schulze Mönking Wilhelm P. Hornung Karl Stricker Gerhard Buchkremer 《European archives of psychiatry and clinical neuroscience》1997,247(1):31-34
This study examines the correlation between development of expressed emotion (EE) in relatives and course of illness of 99
DSM-III schizophrenic patients. Patients whose relatives were high EE at baseline and at the 2nd CFI approximately 20 months
later had a poor prognosis at the very outset of the study and an unfavourable course of illness. They had a higher rehospitalisation
rate, more symptoms, lower psychosocial assessment, and a poorer 2-year and even 8-year outcome. Patients from families with
a fluctuating EE or a consistently low EE had better courses. Expessed emotion is therefore a valid predictor not only of
symptomatic relapses, but also of other important aspects of schizophrenia. The connection between EE index and course of
illness seerns not to be simply reactive or causal, but complex and non-uniform. 相似文献
49.
Siegfried Scherer Gerhard Herrmann Joseph Hirschberg Peter Böger 《Current genetics》1991,19(6):503-507
Summary When only plastidic features are considered, it is difficult to distinguish between monophyletic and polyphyletic xenogenous origins of plastids. We suggest that a direct comparison of nuclear and plastidic sequence-similarity pattern will help to solve this problem. The D1 amino acid sequence of six major groups of photosynthetic eukaryotes and of the two groups of photosynthetic prokaryotes are now available, including the psbA-gene product from Bumilleriopsis filiformis, which is the first molecular sequence reported for a xanthophycean alga. Evidence is provided for an independent and polyphyletic origin of plastids from five out of the six major taxa of photosynthetic eukaryotes. This conclusion is reached by comparing a plastid-based pattern of D1 similarity with a nucleus-based similarity pattern published recently. Furthermore, the availability of D1 sequences from five eukaryotic algae led to a re-evaluation of the taxonomic position of Prochlorothrix. 相似文献
50.